Related Experiment Video
Updated: May 11, 2026

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
Published on: September 1, 2019
Time course changes of anti- and pro-apoptotic proteins in apigenin-induced genotoxicity
Fotini Papachristou1, Ekaterini Chatzaki, Athanasios Petrou
1Cell Cultures Unit, Laboratory of Experimental Surgery and Surgical Research, Faculty of Medicine, Democritus University of Thrace, Dragana, Alexandroupolis, Greece. atsarouc@med.duth.gr.
Background:
Apigenin (4',5,7-trihydroxyflavone, AP), an active component of many medicinal Chinese herbs, exhibits anticancer properties in vitro and in vivo. This study aims to investigate the genotoxic, cytostatic, and cytotoxic effects of AP and time course changes in the levels of anti- and pro-apoptotic proteins involved in the DNA damage response in HepG2 cells.
Methods:
The genotoxic potential of AP was determined by sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) analysis. The levels of cytostaticity and cytotoxicity were evaluated by the proliferation rate and mitotic indices, respectively. MTT was used to study cytotoxicity, while the induction of apoptosis and the expression of apoptosis-related proteins were determined by ELISA.
Results:
At concentrations greater than 10 μM, AP decreased cell survival in a dose- (48 h: 10 vs. 20 μΜ, P < 0.001 and 20 vs. 50 μΜ, P = 0.005; 72 h: 10 vs. 20 μΜ, P < 0.001 and 20 vs. 50 μΜ, P = 0.001) and time-dependent manner (20 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P = 0.003; 50 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P < 0.001; 100 μΜ: 24 vs. 48 h, P < 0.001 and 48 vs. 72 h, P < 0.001). SCEs rates, cell proliferation, and mitotic divisions were also affected in a dose-dependent manner (P < 0.001). There was no change in the frequency of aberrant cells (1 μΜ ΑP: P = 0.554; 10 μM AP: P = 0.337; 20 μΜ AP: P = 0.239). Bcl-2 levels were reduced 3 h after AP administration (P = 0.003) and remained reduced throughout the 48 h observation period (6 h, P = 0.044; 12 h, P = 0.001; 24 h, P = 0.042; 48 h, P = 0.012). Bax and soluble Fas exhibited a transient upregulation 24 h after AP treatment. The Bax/Bcl-2 ratio was also increased at 12 h and remained increased throughout the 48 h observation period.
Conclusion:
AP exhibited dose-dependent genotoxic potential in HepG2 cells. The protein levels of sFas, Bcl-2, and Bax were affected by AP to promote cell survival and cell death, respectively.
Insights
Apigenin (AP) shows anticancer potential by inducing genotoxicity and altering apoptotic protein levels in HepG2 cells. This natural compound affects cell survival and DNA damage response pathways.
Area of Science:
- Pharmacology
- Cell Biology
- Genetics
Background:
- Apigenin (AP), a natural compound from medicinal herbs, has demonstrated in vitro and in vivo anticancer properties.
- This study investigates AP's effects on HepG2 cells, focusing on genotoxicity, cytostasis, and apoptosis.
Purpose of the Study:
- To evaluate the genotoxic, cytostatic, and cytotoxic effects of Apigenin (AP) in HepG2 cells.
- To analyze time-dependent changes in anti- and pro-apoptotic protein levels following AP treatment.
Main Methods:
- Genotoxicity assessed via sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs).
- Cytotoxicity and cytostaticity evaluated using MTT assays, proliferation rates, and mitotic indices.
- Apoptosis induction and related protein expression (Bax, Bcl-2, sFas) determined by ELISA.
Main Results:
- Apigenin decreased HepG2 cell survival in a dose- and time-dependent manner.
- SCE rates and cell proliferation were significantly affected by AP in a dose-dependent way.
- Apigenin treatment altered levels of apoptosis-related proteins, including reduced Bcl-2 and increased Bax and soluble Fas, influencing the Bax/Bcl-2 ratio.
Conclusions:
- Apigenin exhibits dose-dependent genotoxic effects in HepG2 cells.
- AP modulates the expression of sFas, Bcl-2, and Bax, influencing both cell survival and cell death pathways.
Related Concept Videos
Mutagenicity and Carcinogenicity
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle